EpiBiologics

EpiBiologics is a biotechnology company that builds next-generation antibody-based protein degradation platforms for membrane and extracellular drug targets, with the mission to develop first-in-class and best-in-class antibody-targeted therapies based on antibodies, targeting membrane and extracellular proteins that drive underlying disease biology.